Cargando…
Androgen receptor expression in low grade serous ovarian cancer; clinical considerations in the diagnosis, treatment and surveillance of disease in a transgender male
• Low grade serous (LGS) ovarian cancer is an uncommon cancer. • Androgen receptor expression testing is not routinely performed in patients with LGS ovarian cancer. • Systemic androgen levels may be elevated in patients with PCOS or those taking exogenous testosterone. • Consideration should be mad...
Autores principales: | Smrz, Stacy A, Chapman, Graham, Gordon, Jennifer, Bagby, Christina, Nascimento, Alessandra, Ferguson, Lindsay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160689/ https://www.ncbi.nlm.nih.gov/pubmed/37152242 http://dx.doi.org/10.1016/j.gore.2023.101190 |
Ejemplares similares
-
Serous Borderline Tumor in Transgender Female-to-Male Individuals: A Case Report of Androgen Receptor-Positive Ovarian Cancer
por: Ferreira, Cristina, et al.
Publicado: (2021) -
A serous borderline ovarian tumour in a transgender male adolescent
por: Millington, Kate, et al.
Publicado: (2020) -
A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancer
por: Limaye, Sewanti, et al.
Publicado: (2020) -
Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018) -
Addendum: A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancer
por: Limaye, Sewanti, et al.
Publicado: (2022)